From the AGA Journals

Vary CRC screening by age, sex, race, ethnicity?

View on the News

Understanding phenotypic features may enhance identification

In a perfect world, we would be able to identify persons who are going to develop colon cancer. We would screen only these individuals in order to reduce their risk. The next best thing would be to try to identify those at increased risk of colon cancer and target them for appropriate screening. We should aim to minimize unnecessary screening procedures and reduce the risk of avoidable complications. The study by Dr. Lieberman brings us closer to stratifying average-risk individuals by race/ethnicity and sex, based on the prevalence of colonic neoplasia using polyps greater than 9 mm as a surrogate.

The authors studied more than 300,000 average-risk persons undergoing screening colonoscopy from diverse clinical practice settings. In general, the prevalence of large polyps and tumors increased with age, but women had lower prevalence when compared with men. Furthermore, they found that, when compared with whites, blacks had higher prevalence of large polyps while Hispanics had lower risk.

As we move deeper into the era of personalized medicine, understanding the phenotypic features of individuals with a higher risk of colon cancer such as those suggested in the current study may enhance identification of more reliable molecular predictors of higher risk among average-risk persons.

Dr. Adeyinka O. Laiyemo is in division of gastroenterology, department of medicine, Howard University, Washington. He has no conflicts of interest.


 

FROM GASTROENTEROLOGY

References

Among adults at average risk for colorectal cancer who undergo screening colonoscopy, the yield of large polyps and tumors varies widely by patient age, sex, race, and ethnicity. This means that an across-the-board recommendation to initiate screening for all patients at a particular age "may not appear rational and could negatively impact adherence," Dr. David A. Lieberman and his colleagues said in the August issue of Gastroenterology (doi:org/10.1053/j.gastro.2014.04.037).

In what they described as "the largest and most comprehensive analysis of average-risk screening with colonoscopy in the United States," the investigators found that the rate of detecting large (and therefore likely advanced) neoplastic lesions was much higher or lower at any given age, depending on the patient’s sex, race, and ethnicity. So the fact that most practice guidelines uniformly recommend initiating colonoscopy screens at age 50 years doesn’t make sense.

Dr. David Lieberman

"We believe these data, combined with [those of] prior studies, are compelling enough to consider customization of the initiation age of screening based on the risk of large polyps," said Dr. Lieberman and his associates at Oregon Health & Science University, Portland.

They analyzed information from the Clinical Outcomes Research Initiative database, which includes endoscopy findings from 84 diverse practice settings across the country that are representative of all U.S. community, academic, and Veterans Administration endoscopy centers. They included 327,785 exams of patients aged 40 years and older who were at average risk for colorectal cancer and were screened in 2000 through 2011.

Women accounted for half of the study subjects, except for those examined at VA centers, who were predominately male. The study population was 83.6% white, 5.7% black, and 7.7% Hispanic. More than 95% of the participants were aged 50-79 years.

The outcome of interest was the detection of a polyp or tumor larger than 9 mm. "These large lesions are a surrogate for advanced neoplasia," the investigators said.

The prevalence of large neoplasias rose steadily with increasing age across all races and ethnicities and in both sexes.

Across all age groups, women had a lower prevalence of large polyps than men did, suggesting that the initiation of screening colonoscopy can be safely delayed until age 60 years, at least in white and Hispanic women.

Among men younger than 50 years, the prevalence of large polyps was similar between whites (5.3%) and blacks (5.0%). However, the sample of black men in this age group was small (380 patients), so it is possible that this study was simply underpowered to detect the well-known excess of colorectal neoplasias in younger black men.

The prevalence of large polyps was higher in black men than did white men at all other ages until the age of 70 years, at which point the rates even out. Prevalences were 7.1% vs. 6.2% at 50-54 years, 8.5% vs. 7.4% at 55-59 years, 11.5% vs. 8.6% at 60-64 years, and 12.0% vs. 9.7% at 65-69 years.

Black women had a higher prevalence of large polyps than did white women until age 65 years, when the rates evened out. Prevalences were 5.2% vs. 4.2% at 50-54 years, 6.6% vs. 4.5% at 55-59 years, and 6.9% vs. 5.2% at 60-64 years.

These findings "support intensification of screening in black men and women at age 50 years," Dr. Lieberman and his associates said.

Hispanic men and women had a 25% lower rate of polyps than did whites from age 50 through age 79. This finding suggests that initiation of screening colonoscopy can be delayed in Hispanic men and especially in Hispanic women.

The researchers used white men aged 50-54 years as a reference group to compare rates of detection across the study groups. Screening colonoscopy detected large polyps in 6.2% of white men aged 50-54 years. To achieve a similar yield in Hispanic men or black women, they wouldn’t need to be screened until age 55-59 years. To achieve it in Hispanic women, they wouldn’t need to be screened until age 70-74 years.

This study was supported by the National Institute of Digestive and Kidney Diseases. Dr. Lieberman and his associates reported no relevant financial conflicts of interest.

Recommended Reading

Initial cholecystectomy bests standard approach for suspected common duct stone
MDedge Internal Medicine
Intrahepatic interferon signaling may predict hepatitis C outcome
MDedge Internal Medicine
Hospital use of minimally invasive surgery shows disparity in surgical care nationwide
MDedge Internal Medicine
Genotype 3 HCV linked to greater risk of cirrhosis, liver cancer
MDedge Internal Medicine
ERAS program for colorectal surgery cut length of stay, costs in community setting
MDedge Internal Medicine
Emergency physicians may be overprescribing PPIs
MDedge Internal Medicine
Stage esophageal cancer after neoadjuvant chemo
MDedge Internal Medicine
Laparoscopy found effective alternative to open IBD surgery
MDedge Internal Medicine
Enteral contrast did not add diagnostic benefit in suspected appendicitis
MDedge Internal Medicine
New HCV drugs could boost Part D spending by up to $5.8 billion
MDedge Internal Medicine